Prevalence of infectious agents in patients with systemic sclerosis: defining the control group

Prevalence of infectious agents in patients with systemic sclerosis: defining the control group

___

  • 1. Bilgin H, Kocabaş H, Keşli R. The prevalence of infectious agents in patients with systemic sclerosis. Turk J Med Sci 2015; 45: 1192-1197.
  • 2. Kesli R, Gokturk HS, Erbayrak M, Karabagli P, Terzi Y. Comparison of the diagnostic values of the 3 different stool antigen tests for the noninvasive diagnosis of Helicobacter pylori infection. J Investig Med 2010; 58: 982-986.
  • 3. Us D, Hascelik G. Seroprevalence of Helicobacter pylori infection in an asymptomatic Turkish population. J Infect 1998; 37: 148-150.
  • 4. Kaklikkaya N, Akdogan RA, Ozgur O, Uzun DY, Cobanoglu U, Dinc U, Gungor E, Dabanca PA, Arslan M, Aydin F. Evaluation of a new rapid lateral flow chromatography test for the diagnosis of Helicobacter pylori. Saudi Med J 2006; 27: 799-803.
  • 5. Erzin Y, Altun S, Dobrucali A, Aslan M, Erdamar S, Dirican A, Kocazeybek B. Comparison of two different stool antigen tests for the primary diagnosis of Helicobacter pylori infection in Turkish patients with dyspepsia. Helicobacter 2004; 9: 657-662.